Gadoxetic Acid

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

V08CA10

CAS registry number (Chemical Abstracts Service)

0135326-11-3

Chemical Formula

C23-H30-Gd-N3-O11

Molecular Weight

681

Therapeutic Categories

Contrast medium

Diagnostic agent

Chemical Names

Dihydrogen [N-[(2S)-2-]bis(carboxymethyl)amino]-3-(p-ethoxyphenyl)propyl]-N-[2-[bis(carboxymethyl)amino]ethyl]glycinato(5-)]gadolinate(2-) (WHO)

Dihydrogen [N-{(2S)-2-[bis(carboxymethyl)amino]-3-(4-ethoxyphenyl)propyl}-N-{2-[bis(carboxymethyl)amino]ethyl}glycinato(5-)]gadolinat(2-) (IUPAC)

Gadolinium ethoxybenyldiethylenetriaminepentaacetic acid

Foreign Names

• Acidum gadoxeticum (Latin)
• Gadoxetsäure (German)
• Acide gadoxetique (French)
• Acido gadoxetico (Spanish)

Generic Names

• Gd-EOB-DTPA (IS)
• Gadoxetate Disodium (OS: USAN)
• Eovist (IS)
• SHL-569B (IS)
• ZK-139834 (IS)

Brand Names

• Eovist
  Bayer, United States



• Primovist
  Bayer, Austria; Bayer, Switzerland; Bayer, Germany; Bayer, Spain; Bayer, United Kingdom; Bayer, Hungary; Bayer, Italy; Bayer, Latvia; Bayer, Sweden; Bayer Animal Health, Luxembourg; Bayer Schering, Australia; Bayer Schering, Finland; Bayer Schering Pharma, Norway; Schering, Czech Republic; Schering, Estonia; Schering, Lithuania; Schering, Malta; Schering, Poland; Schering, Slovenia



• Primovist EOB
  Bayer Yakuhin, Japan

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.